1 | 9257806 | alpha-Galactosylceramide (AGL-517) treatment protects mice from lethal irradiation. | Exp Hematol | 1997 Aug |
2 |
2 | 9700507 | Antigen-presenting function of mouse CD1: one molecule with two different kinds of antigenic ligands. | Immunol Rev | 1998 Jun |
2 |
3 | 9759842 | Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes. | J Immunol | 1998 Oct 1 |
3 |
4 | 9782129 | CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. | J Exp Med | 1998 Oct 19 |
3 |
5 | 9826697 | Presentation of peptide antigens by mouse CD1 requires endosomal localization and protein antigen processing. | Proc Natl Acad Sci U S A | 1998 Nov 24 |
2 |
6 | 9952023 | Activation of human Valpha24NKT cells by alpha-glycosylceramide in a CD1d-restricted and Valpha24TCR-mediated manner. | Hum Immunol | 1999 Jan |
4 |
7 | 10346936 | Syntheses of biotinylated alpha-galactosylceramides and their effects on the immune system and CD1 molecules. | J Med Chem | 1999 May 20 |
1 |
8 | 10360961 | A novel recognition motif of human NKT antigen receptor for a glycolipid ligand. | Int Immunol | 1999 Jun |
2 |
9 | 10382765 | Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis. | Eur J Immunol | 1999 Jun |
6 |
10 | 10384104 | A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system. | J Immunol | 1999 Jul 1 |
6 |
11 | 10450506 | Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice. | Immunol Rev | 1999 Jun |
4 |
12 | 10452969 | Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. | J Immunol | 1999 Sep 1 |
1 |
13 | 10452972 | Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide. | J Immunol | 1999 Sep 1 |
4 |
14 | 10499917 | Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Valpha14 natural killer T cells. | J Exp Med | 1999 Sep 20 |
1 |
15 | 10523605 | Binding and antigen presentation of ceramide-containing glycolipids by soluble mouse and human CD1d molecules. | J Exp Med | 1999 Oct 18 |
4 |
16 | 10528160 | Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. | J Immunol | 1999 Nov 1 |
2 |
17 | 10537282 | Antitumor cytotoxicity mediated by ligand-activated human V alpha24 NKT cells. | Cancer Res | 1999 Oct 15 |
1 |
18 | 10570271 | A distinct IL-18-induced pathway to fully activate NK T lymphocytes independently from TCR engagement. | J Immunol | 1999 Dec 1 |
2 |
19 | 10639149 | Involvement of decidual Valpha14 NKT cells in abortion. | Proc Natl Acad Sci U S A | 2000 Jan 18 |
4 |
20 | 10675273 | alpha-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells. | Cell Immunol | 2000 Jan 10 |
3 |
21 | 10692041 | Human invariant valpha24+ natural killer T cells activated by alpha-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells. | Immunology | 2000 Feb |
2 |
22 | 10779745 | Analysis of human V alpha 24+ CD4+ NKT cells activated by alpha-glycosylceramide-pulsed monocyte-derived dendritic cells. | J Immunol | 2000 May 1 |
3 |
23 | 10822576 | Synthesis of NBD-alpha-galactosylceramide and its immunologic properties. | Org Lett | 1999 Aug 12 |
1 |
24 | 10878339 | Membrane lymphotoxin is required for the development of different subpopulations of NK T cells. | J Immunol | 2000 Jul 15 |
2 |
25 | 10882410 | The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes. | Int Immunol | 2000 Jul |
1 |
26 | 10884613 | CD1-mediated antigen presentation of glycosphingolipids. | Microbes Infect | 2000 May |
2 |
27 | 10886786 | Differences in the ligand specificity between CD1d-restricted T cells with limited and diverse T-cell receptor repertoire. | Scand J Immunol | 2000 Jul |
3 |
28 | 10900007 | alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria. | Proc Natl Acad Sci U S A | 2000 Jul 18 |
2 |
29 | 10940881 | Activation of hepatic NKT cells and subsequent liver injury following administration of alpha-galactosylceramide. | Eur J Immunol | 2000 Jul |
2 |
30 | 11035073 | Fas/Fas ligand interactions promote activation-induced cell death of NK T lymphocytes. | J Immunol | 2000 Oct 15 |
1 |
31 | 11099306 | Requirement for IFN-gamma in IL-12 production induced by collaboration between v(alpha)14(+) NKT cells and antigen-presenting cells. | Int Immunol | 2000 Dec |
2 |
32 | 11119508 | Activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans. | Infect Immun | 2001 Jan |
3 |
33 | 11123351 | Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of V alpha 14 NK T cells. | J Immunol | 2001 Jan 1 |
4 |
34 | 11145671 | IL-18 enhances IL-4 production by ligand-activated NKT lymphocytes: a pro-Th2 effect of IL-18 exerted through NKT cells. | J Immunol | 2001 Jan 15 |
3 |
35 | 11145860 | Recognition and function of Valpha14 NKT cells. | Semin Immunol | 2000 Dec |
3 |
36 | 11145862 | Molecular biology of NK T cell specificity and development. | Semin Immunol | 2000 Dec |
1 |
37 | 11150537 | Potent expansion of human natural killer T cells using alpha-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15. | J Immunol Methods | 2001 Jan 1 |
2 |
38 | 11164462 | Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells. | Mech Ageing Dev | 2000 Dec 20 |
3 |
39 | 11257133 | Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis. | J Exp Med | 2001 Mar 19 |
3 |
40 | 11264173 | TRAIL expression by activated human CD4(+)V alpha 24NKT cells induces in vitro and in vivo apoptosis of human acute myeloid leukemia cells. | Blood | 2001 Apr 1 |
2 |
41 | 11304550 | The mouse CD1d-restricted repertoire is dominated by a few autoreactive T cell receptor families. | J Exp Med | 2001 Apr 16 |
4 |
42 | 11306921 | The role of alpha-galactosylceramide-activated Valpha14 natural killer T cells in the regulation of Th2 cell differentiation. | Int Arch Allergy Immunol | 2001 Jan-Mar |
4 |
43 | 11342617 | Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways. | J Immunol | 2001 May 15 |
3 |
44 | 11358978 | CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus. | J Leukoc Biol | 2001 May |
2 |
45 | 11385616 | Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide. | Eur J Immunol | 2001 Jun |
3 |
46 | 11431415 | Crucial amino acid residues of mouse CD1d for glycolipid ligand presentation to V(alpha)14 NKT cells. | Int Immunol | 2001 Jul |
2 |
47 | 11466360 | Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFN-gamma release by liver NKT cells. | J Immunol | 2001 Aug 1 |
1 |
48 | 11489950 | CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes. | J Exp Med | 2001 Aug 6 |
1 |
49 | 11533710 | The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. | Nat Med | 2001 Sep |
2 |
50 | 11564825 | Loss of IFN-gamma production by invariant NK T cells in advanced cancer. | J Immunol | 2001 Oct 1 |
1 |